The motif D loop of human immunodeficiency virus type 1 reverse transcriptase is critical for nucleoside 5′-triphosphate selectivity

被引:17
|
作者
Canard, B
Chowdhury, K
Sarfati, R
Doublié, S
Richardson, CC [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[2] Ecole Super Ingn Luminy, CNRS, F-13288 Marseille 9, France
[3] Inst Pasteur, F-75724 Paris 15, France
关键词
D O I
10.1074/jbc.274.50.35768
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human immunodeficiency virus type 1 reverse transcriptase (RT) has limited homology with DNA and RNA polymerases. The conserved Lys-220 of motif D is a signature of RNA-dependent polymerases. Motif D is located in the "palm" domain and forms a small loop from Thr-215 to Lys-223. This loop is absent from the polymerase I family of DNA-dependent polymerases. Analysis of RT structures in comparison with other polymerases reveals that the motif D loop has the potential to undergo a conformational change upon binding a nucleotide. We find that amino acid changes in motif D affect the interaction of RT with the incoming nucleotide. A chimeric RT in which the loop of motif D is substituted by the corresponding amino acid segment from Tag DNA polymerase lacking this loop has a decreased affinity for incoming nucleotides. We have also constructed a mutant RT where the conserved lysine at position 220 within the motif D is substituted with glutamine. Both RT(K220Q) and the chimeric RT are resistant in vitro to 3'-deoxy S'-azidothymidine 5'-triphosphate (AZTTP). These results suggest that motif D is interacting with the incoming nucleotide and a determinant of the sensitivity of reverse transcriptases to AZTTP. We do not observe any interaction of motif D with the template primer.
引用
收藏
页码:35768 / 35776
页数:9
相关论文
共 50 条
  • [31] Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer
    Wapling, J
    Moore, KL
    Sonza, S
    Mak, J
    Tachedjian, G
    JOURNAL OF VIROLOGY, 2005, 79 (16) : 10247 - 10257
  • [32] Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates
    Whitcomb, JM
    Parkin, NT
    Chappey, C
    Hellmann, NS
    Petropoulos, CJ
    JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (07): : 992 - 1000
  • [33] Identification of a Non-Nucleoside Reverse Transcriptase Inhibitor against Human Immunodeficiency Virus-1
    Kim, Min-Jung
    Yu, Kyung Lee
    Han, Ri
    Lee, Yoonji
    Oh, Kyungsoo
    You, Ji Chang
    ACS INFECTIOUS DISEASES, 2023, 9 (08): : 1582 - 1592
  • [34] Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1
    Starr, SE
    Fletcher, CV
    Spector, SA
    Yong, FH
    Fenton, T
    Brundage, RC
    Manion, D
    Ruiz, NM
    Gersten, M
    Becker, M
    McNamara, J
    Mofenson, LM
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25): : 1874 - 1881
  • [35] Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein
    Peters, S
    Muñoz, M
    Yerly, S
    Sanchez-Merino, V
    Lopez-Galindez, C
    Perrin, L
    Larder, B
    Cmarko, D
    Fakan, S
    Meylan, P
    Telenti, A
    JOURNAL OF VIROLOGY, 2001, 75 (20) : 9644 - 9653
  • [36] Deconstruction of Non-Nucleoside Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Type 1 for Exploration of the Optimization Landscape of Fragments
    Brandt, Peter
    Geitmann, Matthis
    Danielson, U. Helena
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (03) : 709 - 718
  • [37] Mechanistic insights into the suppression of drug resistance by human immunodeficiency virus type 1 reverse transcriptase using α-boranophosphate nucleoside analogs
    Deval, J
    Alvarez, K
    Selmi, B
    Bermond, M
    Boretto, J
    Guerreiro, C
    Mulard, L
    Canard, B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (05) : 3838 - 3846
  • [38] Dipyridodiazepinone Analogs as Human Immunodeficiency Virus Type 1-Specific Non-Nucleoside Reverse Transcriptase Inhibitors: An Overview
    Lv, M.
    Xu, H.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (18) : 1874 - 1898
  • [39] Colorimetric assays for evaluation of the mode of action of human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors
    Shao, X
    Rytting, AS
    Ekstrand, DHL
    Vrang, L
    Kallander, CFR
    Gronowitz, JS
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1998, 9 (02): : 167 - 176
  • [40] Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particles
    Liao, Wei-Hao
    Huang, Kuo-Jung
    Chang, Yu-Fen
    Wang, Shiu-Mei
    Tseng, Ying-Tzu
    Chiang, Chien-Cheng
    Wang, Jaang-Jiun
    Wang, Chin-Tien
    JOURNAL OF VIROLOGY, 2007, 81 (10) : 5155 - 5165